(Circulation. 1999;100:1264-1267.)
© 1999 American Heart Association, Inc.
Brief Rapid Communication |
Homozygous Premature Truncation of the HERG Protein
The Human HERG Knockout
From the Departments of Pediatric Cardiology, University Hospital and Wilhelmina Children's Hospital (T.H., N.S.), Utrecht; the Departments of Clinical Genetics (M.A., K.v.d.L., M.M.), Cardiovascular Pathology (A.v.d.W.), and Clinical and Experimental Cardiology (A.W.), Academic Medical Center, Amsterdam; and the Departments of Medical Genetics (P.v.T.) and Cardiology (A.W.), University Medical Centre Utrecht, Utrecht; and The Interuniversity Cardiology Institute, The Netherlands.
Correspondence to Dr Wilde, Department of Clinical and Experimental Cardiology, AMC Amsterdam, PO BOX 22700, 1100 DE Amsterdam, the Netherlands. E-mail a.a.wilde{at}AMC.UVA.NL
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—In long-QT syndrome (LQTS), heterozygosity for a mutation in 1 of the K+ channel genes leads to prolongation of the cardiac action potential, because the aberrant protein exhibits "loss of function." HERG, which is involved in LQT2, is the gene encoding the rapid component of the delayed rectifier, IKr.
Methods and Results—In a consanguineous family, a stillbirth was followed by the premature birth of a child in distress due to ventricular arrhythmia in the presence of QT prolongation. LQTS was diagnosed, ß-blocker therapy was begun, and a pacemaker was implanted. She developed well and remained symptom-free for 1.5 years. In the index patient, we identified a duplication of bp 558 to 600 in exon 4 of HERG on both alleles. This will result in a frameshift and a premature stop codon before the S1 domain of the HERG protein. Because it is present on both alleles, no functional IKr is anticipated. The same mutation was found heterozygously in both parents and homozygously in the stillborn brother.
Conclusions—It is concluded that absence of IKr gives rise to a severe cardiac phenotype, with no indication of malfunction of any other organ.
Key Words: genetics • torsade de pointes • arrhythmia
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Congenital long-QT syndrome (LQTS) is an inherited disorder characterized by prolongation of the QT interval and the occurrence of polymorphic ventricular arrhythmia leading to recurrent (pre-) syncope or sudden cardiac death. The molecular basis of LQTS is heterogeneous, involving either inadequate opening of K+ channels (LQT types 1, 2, 5, or 6) or inadequate closing of Na+ channels (type 3).1 2 3 4 5 Heterozygosity for a mutation in 1 of the 4 K+ channel genes (LQT1, 2, 5, or 6) gives rise to prolongation of the cardiac action potential, because the aberrant protein encoded by the mutated gene exhibits "loss of function" (ie, less repolarizing K+ current, for example, by a dominant negative effect on channel function).2 6 7 This explains the autosomal-dominant inheritance pattern of Romano-Ward syndrome. Homozygosity for mutations in KVLQT1 and KCNE1 have been associated with the recessively inherited Jervell and Lange-Nielsen syndrome, in which QT prolongation is associated with bilateral sensorineural deafness.8 Recently, a recessively inherited pattern of LQT1 without deafness was described.9
HERG, which is involved in LQT2, is the gene encoding the rapid component of the delayed rectifier IKr.6 In this report, we describe a family in which consanguinity of the parents led to a homozygous mutation in HERG, putatively leading to a "human HERG knockout" in their offspring.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Clinical Data
The study was performed according to a protocol approved by the local ethics committee. The patients studied constitute the offspring of asymptomatic, consanguineous, Mediterranean parents (see inlay in Figure 1
for pedigree). After
the birth of a healthy daughter (II-1, now 5 years of age), 1 child
died in utero at 36 weeks of gestation with intrauterine heart failure
and fetal hydrops (II-2). The index patient (II-3) was followed during
gestation, and she presented in utero with an irregular
heartbeat and a structurally normal heart.
|
Mutation Analysis
DNA was isolated from lymphocytes or amniotic fluid cells and
DNA was extracted from the paraffin-embedded tissues of the
stillborn child using the QIAamp DNA blood minikit (Qiagen). All 15
exons of the HERG gene were amplified from genomic DNA by the
polymerase chain reaction (PCR) primers described.10 PCR
products were analyzed by single-strand conformation
polymorphism on 12.5% nondenaturating polyacrylamide
gels run at 5°C and 15°C, as described in GeneExcel protocols
(Pharmacia Biotech). DNA was stained using a silver staining kit
(Pharmacia Biotech). Fragments presenting aberrant conformers were
sequenced by the dideoxy chain termination method on an ABI 310
automatic sequencer (Applied Biosystems). Segregation of the
43-bp duplication in exon 4 in the family was determined by an
analysis of the exon 4A PCR product on a 2% agarose/EtBr
gel. A total of 100 control individuals were tested for the presence of
the mutation.
Pathology
At necropsy of the stillborn child, a normotrophic heart was
diagnosed macroscopically. Paraffin blocks containing 4 full-thickness
segments of the left (n=3) and right ventricular wall (n=1)
were obtained. The 5-mm sections were stained with hematoxylin and
eosin, elastic van Gieson, and van Kossa stains, respectively.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patients
The index patient (II-3) was examined shortly after birth. She had no external dysmorphic features (weight, 2.1 kg; length, 46 cm). All pulses were palpable. Heart rate was irregular. The heart was structurally normal on echocardiography, with moderate ventricular function.
The ECG obtained shortly after birth showed a relative sinus
bradycardia (120/min), a PR interval and a QRS width of normally
conducted impulses of, respectively, 120 and 60 ms, and a right axis
(Figure 1
). There was 2:1 functional
atrioventricular (AV) block, with multiform
ventricular ectopy arising from the grossly abnormal
TU complex. The QTc interval was 580 ms. Ventricular
arrhythmias of the torsade de pointes type were observed, and
the child deteriorated rapidly. Treatment with oral
propranolol was instituted, leading to a significant
reduction of ventricular arrhythmia. On day 2,
polymorphic ventricular tachycardia was
successfully terminated with intravenous magnesium sulfate
(0.4 mmol/kg). Because 2:1 AV block persisted in the presence of
ß-blockade, permanent transvenous ventricular pacing was
established on day 3, with a lowest rate setting of 100 beats/min.
ß-Blocker therapy was continued. Auditory evoked-response testing
performed on day 7 of life showed a normal response at 70, 60, and 50
dB. The girl remained symptom-free at a follow-up of 1.5 years. She
remains 100% paced.
Subject II-2 died in utero at 36 weeks of gestation with intrauterine
heart failure and fetal hydrops. Heart weight recorded at autopsy
was 15 g (normal weight is 16±4.3 g at 36 weeks of gestation).
Histologic examination of the heart showed diffuse endocardial
fibroelastosis in all sections (Figure 2). The myocardium showed
thin, stretched bundles of myocardial cells partially arranged in a
wavy pattern. Multifocal areas of calcification and extracellular
myocardial calcium deposition were observed subendocardially in the
left ventricular wall (Figure 2). Moreover, distinct
areas of coagulative necrosis were present. Inborn errors of
metabolism were excluded as a cause of the
cardiomyopathy.
|
The eldest daughter (II-1) was in good health at 5 years of age. Her ECG was normal, with a morphologically normal ST segment (QTc, 415 ms). Both the father (I-1, 28 years of age) and the mother (I-2, 24 years of age) had morphologically abnormal T-waves of slightly prolonged duration (QTc, respectively, was 440 and 450 ms). They never experienced any symptom compatible with LQTS. In their relatively large families (10 siblings and 16 children, respectively), with the exception of 1 stillbirth (details unknown), no individual was symptomatic or died prematurely. All grandparents were alive and, apparently, in good health.
HERG Analysis
We identified a duplication of bp 558 to 600 in exon 4 of HERG,
which resulted in a frameshift and a premature stop codon before the
putative S1 domain, that eliminates the transmembrane domain of the
protein. In the index patient, this duplication was present on both
alleles, so no functional HERG protein is anticipated. The same
mutation was found heterozygously in both parents; it was not
present in the healthy sister or in 100 control individuals.
Analysis of DNA isolated from amniotic fluid cells and
paraffin-embedded tissues derived from the stillborn brother revealed
that he also carried the duplication homozygously.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
HERG is the gene encoding IKr, the rapid component of the delayed rectifier. Heterozygous missense mutations and mutations giving rise to premature translation stops are causally involved in LQT2.1 The HERG mutation described in the present family is expected to lead to premature truncation of the protein (before the S1 domain). The parents are consanguineous, and both are heterozygous for the mutation. The phenotype of the heterozygous state is apparently mild, with slightly abnormal QT intervals in both parents morphologically. In addition, the parents and their siblings are asymptomatic, and no suspected premature sudden cardiac death has occurred in 3 generations.
In contrast, homozygosity translated phenotypically into profound QT prolongation, with 2:1 (functional) AV block and severe ventricular arrhythmias before and immediately after birth in 1 child. This child was carefully followed in the prenatal period because a previous pregnancy ended with an in utero death at an estimated gestational age of 36 weeks. The boy, in whom homozygosity for the mutation could be demonstrated, died in a decompensated state, as evidenced by the autopsy findings. A causal relation with the proven genetic abnormality can only be speculated, but it seems reasonable to suggest that severe ventricular arrhythmia was responsible for the intrauterine death, the more so because other causes of myocardial necrosis (ie, myocarditis and aberrant course of coronary arteries) could be excluded. The histopathological findings, ie, a markedly dilated heart with diffuse fibroelastosis, stretching of myocardial fiber bundles, areas of coagulative necrosis (recent ischemia), and multiple calcified scars (old infarction), agree with the suggestion of repetitive episodes of ischemia due to arrhythmia and provide an explanation for the cardiac failure and intrauterine death of the infant.
Clinical characteristics of LQTS with 2:1 functional AV block were recently reviewed.11 Twelve of 22 patients who were diagnosed in infancy died young.11 On clinical grounds, the majority of affected children were defined as "sporadic cases," and de novo mutations were suggested.11 An alternative hypothesis is suggested by these cases, ie, the homozygous expression of HERG (or KVLQT1) mutations may lead to a severe phenotype. Indeed, it is becoming increasingly clear that LQTS, based on heterozygously expressed mutants, may appear with a very low penetrance.12
As the mutation is expected to lead to premature truncation of the channel protein, homozygosity for the mutation will result in complete absence of IKr. Interestingly, no other phenotypic expression seems to be present in our patients, suggesting a limited role of HERG in other human organ systems. In particular, no deafness is present, and psychomotor development appears normal. The (human) phenotype may, however, be lethal due to severe cardiac arrhythmias.
In conclusion, in humans, the absence of functional IKr leads to a severe cardiac phenotype characterized by QT prolongation, functional AV conduction disturbances, and polymorphic ventricular arrhythmias. No evidence of dysfunction in any other organ exists.
|
Acknowledgments |
|---|
We thank the family members and the referring physicians, Drs van der Zijden and Westenend (pediatrician and pathologist, Beatrix Hospital, Gorinchem, The Netherlands) for their participation. Dr Wilde is a clinical investigator for the Dutch Heart Foundation (NHS, grant D95/014).
Received May 21, 1999; revision received July 29, 1999; accepted August 5, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803.[Medline] [Order article via Infotrieve]
2. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, De Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23.[Medline] [Order article via Infotrieve]
3. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997;17:338–340.[Medline] [Order article via Infotrieve]
4. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–811.[Medline] [Order article via Infotrieve]
5. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SAN. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175–187.[Medline] [Order article via Infotrieve]
6. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307.[Medline] [Order article via Infotrieve]
7. Chouabe C, Neyroud N, Guicheney P, Lazdunski M, Romey G, Barhanin J. Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 1997;16:5472–5479.[Medline] [Order article via Infotrieve]
8.
Splawski I, Timothy KW, Vincent GM, Atkinson DL,
Keating MT. Molecular basis of the long QT syndrome associated with
deafness. N Engl J Med. 1997;336:1562–1567.
9.
Priori SG, Schwartz PJ, Napolitano C, Bianchi L,
Dennis A, De Fusco M, Brown AM, Casari G. A recessive variant of the
Romano-Ward long-QT syndrome. Circulation. 1998;97:2420–2425.
10. Itoh T, Tanaka T, Nagai R, Kamiya T, Sawayama T, Nakayama T, Tomoike H, Sakurada H, Yazaki Y, Nakamura Y. Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum Genet. 1998;102:435–439.[Medline] [Order article via Infotrieve]
11. Gorgels APM, Al Fadley F, Zaman L, Kantoch MJ, Al Halees Z. The long QT syndrome with impaired atrioventricular conduction: a malignant variant in infants. J Cardiovasc Electrophysiol. 1999;9:1225–1232.
12.
Priori SG, Napolitano C, Schwartz PJ. Low penetrance in
the long-QT syndrome: clinical impact. Circulation. 1999;99:529–533.
This article has been cited by other articles:
 |
|
 |
|
  G. Q. Teng, X. Zhao, J. P. Lees-Miller, F. R. Quinn, P. Li, D. E. Rancourt, B. London, J. C. Cross, and H. J. Duff Homozygous Missense N629D hERG (KCNH2) Potassium Channel Mutation Causes Developmental Defects in the Right Ventricle and Its Outflow Tract and Embryonic Lethality Circ. Res., December 5, 2008; 103(12): 1483 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Clusin Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H1 - H10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Medeiros-Domingo, T. Kaku, D. J. Tester, P. Iturralde-Torres, A. Itty, B. Ye, C. Valdivia, K. Ueda, S. Canizales-Quinteros, M. T. Tusie-Luna, et al. SCN4B-Encoded Sodium Channel 4 Subunit in Congenital Long-QT Syndrome Circulation, July 10, 2007; 116(2): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Arnaout, T. Ferrer, J. Huisken, K. Spitzer, D. Y. R. Stainier, M. Tristani-Firouzi, and N. C. Chi Zebrafish model for human long QT syndrome PNAS, July 3, 2007; 104(27): 11316 - 11321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Heradien, A. Goosen, L. Crotti, G. Durrheim, V. Corfield, P. A. Brink, and P. J. Schwartz Does Pregnancy Increase Cardiac Risk for LQT1 Patients With the KCNQ1-A341V Mutation? J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1410 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaab and E. Schulze-Bahr Susceptibility genes and modifiers for cardiac arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 397 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Milan and C. A. MacRae Animal models for arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 426 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Recurrent syncope Postgrad. Med. J., March 1, 2005; 81(953): 202 - 202. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D.J. Ten Harkel, M. Witsenburg, P. L. de Jong, L. Jordaens, M. Wijman, and A. A.M. Wilde Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias Europace, January 1, 2005; 7(1): 77 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. McNair, L. Ku, M. R.G. Taylor, P. R. Fain, D. Dao, E. Wolfel, L. Mestroni, and the Familial Cardiomyopathy Registry Research Grou SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia Circulation, October 12, 2004; 110(15): 2163 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Schwartz Stillbirths, Sudden Infant Deaths, and Long-QT Syndrome: Puzzle or Mosaic, the Pieces of the Jigsaw Are Being Fitted Together Circulation, June 22, 2004; 109(24): 2930 - 2932. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chugh, O. Senashova, A. Watts, P. T. Tran, Z. Zhou, Q. Gong, J. L. Titus, and S. J. Hayflick Postmortem molecular screening in unexplained sudden death J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1625 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Lupoglazoff, I. Denjoy, E. Villain, V. Fressart, F. Simon, A. Bozio, M. Berthet, N. Benammar, B. Hainque, and P. Guicheney Long QT syndrome in neonates: Conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations J. Am. Coll. Cardiol., March 3, 2004; 43(5): 826 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Lees-Miller, J. Guo, J. R. Somers, D. E. Roach, R. S. Sheldon, D. E. Rancourt, and H. J. Duff Selective Knockout of Mouse ERG1 B Potassium Channel Eliminates IKr in Adult Ventricular Myocytes and Elicits Episodes of Abrupt Sinus Bradycardia Mol. Cell. Biol., March 15, 2003; 23(6): 1856 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bezzina, M. B. Rook, W.A. Groenewegen, L. J. Herfst, A. C. van der Wal, J. Lam, H. J. Jongsma, A. A.M. Wilde, and M. M.A.M. Mannens Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System Circ. Res., February 7, 2003; 92(2): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R Bezzina and H. L Tan Pharmacological rescue of mutant ion channels Cardiovasc Res, August 1, 2002; 55(2): 229 - 232. [Full Text] [PDF]
|
|
|
|
|
|
J.M. Lupoglazoff, T. Cheav, G. Baroudi, M. Berthet, I. Denjoy, B. Cauchemez, F. Extramiana, M. Chahine, and P. Guicheney Homozygous SCN5A Mutation in Long-QT Syndrome With Functional Two-to-One Atrioventricular Block Circ. Res., July 20, 2001; 89 (2): e16 - e21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Clancy and Y. Rudy Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death Cardiovasc Res, May 1, 2001; 50(2): 301 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Thomas, G. Wendt-Nordahl, K. Röckl, E. Ficker, A. M. Brown, and J. Kiehn High-Affinity Blockade of Human Ether-A-Go-Go-Related Gene Human Cardiac Potassium Channels by the Novel Antiarrhythmic Drug BRL-32872 J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 753 - 761. [Abstract] [Full Text]
|
|
|
|
|
|
B. London, A. A.M. Wilde, M. M.A.M. Mannens, M. Alders, K. van der Lip, T. M. Hoorntje, N. Sreeram, P. van Tintelen, and A. van der Wal A Knockout May Not Always Be a Knockout Response Circulation, October 31, 2000; 102 (18): e122 - e122. [Full Text] [PDF]
|
|
|
|
|
|
I. Splawski, J. Shen, K. W. Timothy, M. H. Lehmann, S. Priori, J. L. Robinson, A. J. Moss, P. J. Schwartz, J. A. Towbin, G. M. Vincent, et al. Spectrum of Mutations in Long-QT Syndrome Genes : KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation, September 5, 2000; 102(10): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-E. Chiang and D. M. Roden The long QT syndromes: genetic basis and clinical implications J. Am. Coll. Cardiol., July 1, 2000; 36(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||